Research Funding

  • August 15, 2017 - July 31, 2022 - Research training in HIV-related transfusion medicine and hematology in South Africa , Principal Investigator . Sponsor: NIH, Sponsor Award ID: D43TW010345
  • April 1, 2013 - March 31, 2017 - Recipient Epidemiology and Donor Evaluation Study III (REDS-III) Internat'l Site , Principal Investigator . Sponsor: NIH, Sponsor Award ID: 268201100009I-2-26800002-1
  • March 15, 2013 - March 14, 2017 - Recipient Epidemiology and Donor Evaluation Study III (REDS-III) Domestic Hub , Principal Investigator . Sponsor: NIH, Sponsor Award ID: 268201100005I-2-26800002-1
  • January 5, 2004 - May 31, 2016 - Health Outcomes in Blood Donors and Recipients , Principal Investigator . Sponsor: NIH, Sponsor Award ID: K24HL075036
  • June 1, 2011 - May 31, 2012 - XV International Conference on Human Retrovirology: HTLV and Related Viruses , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R13CA159758
  • April 12, 1999 - January 31, 2010 - Pathophysiology of HTLV-I and HTLV-II Infection , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R01HL062235
  • June 1, 2003 - May 31, 2008 - XI International Conference on Human Retrovirology: HTLV , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R13CA098290
  • September 16, 1994 - September 30, 2003 - RETROVIRUS EPIDEMIOLOGY DONOR STUDY (REDS) BLOOD CENTER , Principal Investigator . Sponsor: NIH/NHLBI, Sponsor Award ID: N01HB047114
  • August 15, 1997 - June 30, 2003 - MEDICAL CONSEQUENSES OF HTLV II IN DRUG ABUSERS , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R01DA011241
  • December 1, 1994 - November 30, 1999 - VIRAL ACTIVATION TRANSFUSION STUDY , Principal Investigator . Sponsor: NIH/NHLBI, Sponsor Award ID: N01HB057121
  • July 17, 1989 - September 15, 1994 - EPIDEMIOLOGIC STUDIES OF HUMAN RETROVIRUSES IN BLOOD , Principal Investigator . Sponsor: NIH/NHLBI, Sponsor Award ID: N01HB097077
  • July 19, 1996 - January 1, 1900 - MOLECULAR EPIDEMIOLOGY OF HTLV-II , Principal Investigator . Sponsor: NIH, Sponsor Award ID: F06TW002148

Education

Massachusetts Institute of Technology, B.S., 1974, Marine Biology
Stanford University, Stanford, CA, M.D., 1980, Medicine
University of California, Berkeley, CA, M.P.H., 1981, Epidemiology

Honors & Awards

  • 1970
    Westinghouse Scholarship
  • 1980-81
    University of California Graduate Scholarship
  • 1984
    Chateaubriand prize of the French Government
  • 1984
    International Agency for Cancer Research Fellowship (declined)
  • 1988
    FDA Commissioners Special Citation
  • 1989-92
    Charles E. Culpeper Scholarship
  • 1995-96
    Fulbright Scholarship, France
  • 1995-96
    NIH Fogarty Senior International Fellowship
  • 2003
    President, International Retrovirology Association

Selected Publications

  1. Cosgrave EJ, Blake M, Murphy E, Sheridan A, Doyle F, Kavanagh P. Is the public ready for a tobacco-free Ireland? A national survey of public knowledge and attitudes to tobacco endgame in Ireland. Tob Control. 2024 Oct 19; 33(6):807-812.  View on PubMed
  2. Sheridan A, Conway R, Murphy E, Blake M, Mulcahy M, Howell F, Gordon C, Doyle F, Kavanagh PM. The impact of the introduction of tobacco product plain packaging on consumer responses in Ireland: a real-world policy evaluation stratified by socioeconomic groups. Eur J Public Health. 2024 Oct 01; 34(5):970-978.  View on PubMed
  3. Willemse RJ, Grobler CJ, Murphy EL, Roubinian N, Colemen C, Machaba S, Vermeulen M. The prevalence of hepatitis B virus, human T-lymphotropic virus and human immunodeficiency virus in patients receiving blood transfusions in South Africa. Vox Sang. 2024 Nov; 119(11):1166-1173.  View on PubMed
  4. Joseph J, Premeaux TA, Tandon R, Murphy EL, Bruhn R, Nicot C, Herrera BB, Lemenze A, Alatrash R, Baffour Tonto P, Ndhlovu LC, Jain P. Dendritic Cells Pulsed with HAM/TSP Exosomes Sensitize CD4 T Cells to Enhance HTLV-1 Infection, Induce Helper T-Cell Polarization, and Decrease Cytotoxic T-Cell Response. Viruses. 2024 Sep 10; 16(9).  View on PubMed
  5. van den Berg K, Murphy EL, Maartens G, Louw VJ, Grebe E. The impact of non-disclosure of HIV status and antiretroviral therapy on HIV recency testing and incidence algorithms. Vox Sang. 2024 Jun; 119(6):581-589.  View on PubMed
  6. Shichijo T, Yasunaga JI, Sato K, Nosaka K, Toyoda K, Watanabe M, Zhang W, Koyanagi Y, Murphy EL, Bruhn RL, Koh KR, Akari H, Ikeda T, Harris RS, Green PL, Matsuoka M. Vulnerability to APOBEC3G linked to the pathogenicity of deltaretroviruses. Proc Natl Acad Sci U S A. 2024 Mar 26; 121(13):e2309925121.  View on PubMed
  7. Jentsch U, Vermeulen M, van den Berg K, Swanevelder R, Creel D, Jacobs G, Hemingway-Foday JJ, Nyoni C, Murphy EL, Custer B. A case-control study of risk factors for incident hepatitis B virus infection in South African blood donors. Int J Infect Dis. 2024 Apr; 141:106958.  View on PubMed
  8. Murphy EL. HTLV-1 and blood donation. Br J Haematol. 2024 01; 204(1):29-30.  View on PubMed
  9. Jacobs G, Van den Berg K, Vermeulen M, Swanevelder R, Custer B, Murphy EL. Association of ABO and RhD blood groups with the risk of HIV infection. PLoS One. 2023; 18(4):e0284975.  View on PubMed
  10. van den Berg K, Murphy EL, Louw VJ, Maartens G, Hughes SD. Motivations for blood donation by HIV-positive individuals on antiretrovirals in South Africa: A qualitative study. Transfus Med. 2023 Aug; 33(4):277-286.  View on PubMed
  11. Assone T, Menezes SM, de Toledo Gonçalves F, Folgosi VA, da Silva Prates G, Dierckx T, Braz M, Smid J, Haziot ME, Marcusso RMN, Dahy FE, Vanderlinden E, Claes S, Schols D, Bruhn R, Murphy EL, Penalva de Oliveira AC, Daelemans D, Vercauteren J, Casseb J, Van Weyenbergh J. Systemic cytokines and GlycA discriminate disease status and predict corticosteroid response in HTLV-1-associated neuroinflammation. J Neuroinflammation. 2022 Dec 08; 19(1):293.  View on PubMed
  12. van den Berg K, Vermeulen M, Bakkour S, Stone M, Jacobs G, Nyoni C, Barker C, McClure C, Creel D, Grebe E, Roubinian N, Jentsch U, Custer B, Busch MP, Murphy EL. Blood Center Testing Allows the Detection and Rapid Treatment of Acute and Recent HIV Infection. Viruses. 2022 10 23; 14(11).  View on PubMed
  13. Vermeulen M, van Schalkwyk C, Jacobs G, van den Berg K, Stone M, Bakkour S, Custer B, Jentsch U, Busch MP, Murphy E, Grebe E. The Impact of Early Antiretroviral Treatment (ART) for HIV on the Sensitivity of the Latest Generation of Blood Screening and Point of Care Assays. Viruses. 2022 06 29; 14(7).  View on PubMed
  14. Miranda C, Utsch-Gonçalves D, Piassi FCC, Loureiro P, Gomes I, Ribeiro MA, de Almeida-Neto C, Blatyta P, Amorim L, Garcia Mateos SO, Murphy EL, Custer B, Carneiro-Proietti ABF, Sabino EC. Prevalence and Risk Factors for Human T-Cell Lymphotropic Virus (HTLV) in Blood Donors in Brazil-A 10-Year Study (2007-2016). Front Med (Lausanne). 2022; 9:844265.  View on PubMed
  15. Kim D, Myllymäki M, Kankainen M, Jarvinen T, Park G, Bruhn R, Murphy EL, Mustjoki S. Somatic STAT3 mutations in CD8+ T cells of healthy blood donors carrying human T-cell leukemia virus type 2. Haematologica. 2022 02 01; 107(2):550-554.  View on PubMed
  16. Valencia A, Vergara C, Thio CL, Vince N, Douillard V, Grifoni A, Cox AL, Johnson EO, Kral AH, Goedert JJ, Mangia A, Piazzolla V, Mehta SH, Kirk GD, Kim AY, Lauer GM, Chung RT, Price JC, Khakoo SI, Alric L, Cramp ME, Donfield SM, Edlin BR, Busch MP, Alexander G, Rosen HR, Murphy EL, Wojcik GL, Carrington M, Gourraud PA, Sette A, Thomas DL, Duggal P. Trans-ancestral fine-mapping of MHC reveals key amino acids associated with spontaneous clearance of hepatitis C in HLA-DQβ1. Am J Hum Genet. 2022 02 03; 109(2):299-310.  View on PubMed
  17. Marqué L, Liehl P, De Boer J, Pottel H, Murphy EL, Bruhn R, Stone M, Kaidarova Z, Lee TH, Busch M, Zrein M. A novel high performing multiplex immunoassay Multi-HTLV for serological confirmation and typing of HTLV infections. PLoS Negl Trop Dis. 2021 11; 15(11):e0009925.  View on PubMed
  18. Rapodile T, Mitchel J, Swanevelder R, Murphy EL, van den Berg K. Re-engineering the medical assessment of blood donors in South Africa: The balance between supply and safety. Transfusion. 2021 12; 61(12):3361-3371.  View on PubMed
  19. van den Berg K, Vermeulen M, Louw VJ, Murphy EL, Maartens G. Undisclosed HIV status and antiretroviral therapy use among South African blood donors. Transfusion. 2021 08; 61(8):2392-2400.  View on PubMed
  20. Vermeulen M, Swanevelder R, Van Zyl G, Lelie N, Murphy EL. An assessment of hepatitis B virus prevalence in South African young blood donors born after the implementation of the infant hepatitis B virus immunization program: Implications for transfusion safety. Transfusion. 2021 09; 61(9):2688-2700.  View on PubMed

Go to UCSF Profiles, powered by CTSI